← Open Payments lookup

REBECCA BOSS: Open Payments

NPI 1811549959 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,000 in 85 payments from 21 companies in 2025. Trend: 2023 $785 · 2024 $848 · 2025 $2,000

Food & beverage: $2,000
CompanyPaymentsAmount
Galderma Laboratories, L.P.14$279
GENZYME CORPORATION11$268
Botanix SB Inc6$206
ABBVIE INC.10$179
Incyte Corporation6$157
MERZ NORTH AMERICA, INC.2$153
LEO Pharma Inc.5$123
Regeneron Healthcare Solutions, Inc.4$105
Almirall LLC4$99
UCB, Inc.3$71

Products named: DUPIXENT, SOFDRA, OPZELURA, Xeomin, ADBRY, Bimzelx, NEMLUVIO, RINVOQ.

Industry payments across TX — which companies pay providers there.